Taiwan Otsuka announces voluntarily recall of Abilify 5mg and 30mg .For the recalled products, the potential for serious harm to patients' health is very low, and to date, also we have not received any reports of health damage caused .
Taiwan Otsuka Pharmaceutical, driven by the spirit of corporate social responsibility and hospitality, has donated NT$1 million to assist disaster victims.
The first POCARI hiking event was held on Saturday, March 30th, 2024, which attracted more than 1,000 participants.
Otsuka Pharmaceutical, as a global pharmaceutical company
We are committed to research and develop the innovative medicines through the global integration between Asian, American and European research institutions, and providing innovative, effective and safe products for patients worldwide.
Otsuka Pharmaceutical has been in the infusion business for more than 70 years, and as a leader in the infusion industry, has contributed to the history of infusion development.
MOREBased on professional clinical nutrition, Otsuka Pharmaceutical creates medical food with clinical evidence, and becomes the best partner of patients and medical personnels.
MOREProviding breakthrough treatments for patients around the world
Pharmaceutical Business
Nutraceutical Business
Health Education